These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34675389)

  • 1. Immune-mediated inflammation across disease boundaries: breaking down research silos.
    Buckley CD; Chernajovsky L; Chernajovsky Y; Modis LK; O'Neill LA; Brown D; Connor R; Coutts D; Waterman EA; Tak PP
    Nat Immunol; 2021 Nov; 22(11):1344-1348. PubMed ID: 34675389
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: update on inflammatory targets modulating atherogenesis.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the Toll-like receptor pathway as a therapeutic strategy for neonatal infection.
    Dias ML; O'Connor KM; Dempsey EM; O'Halloran KD; McDonald FB
    Am J Physiol Regul Integr Comp Physiol; 2021 Dec; 321(6):R879-R902. PubMed ID: 34612068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe.
    Libby P; Mallat Z; Weyand C
    Cardiovasc Res; 2021 Nov; 117(13):2503-2505. PubMed ID: 34698765
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-inflammatory Treatment for Seemingly Non-inflammatory Disorders. Editorial.
    Maru Y
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):82. PubMed ID: 26004772
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Cellular Stress and Inflammation: How the Immune System Drives Tissue Homeostasis.
    Antonangeli F; Grimsholm O; Rossi MN; Velotti F
    Front Immunol; 2021; 12():668876. PubMed ID: 33828567
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 10. Interplay between inflammation and thrombosis in cardiovascular pathology.
    Stark K; Massberg S
    Nat Rev Cardiol; 2021 Sep; 18(9):666-682. PubMed ID: 33958774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-metabolic interfaces in cardiac disease and failure.
    Bertero E; Dudek J; Cochain C; Delgobo M; Ramos G; Gerull B; Higuchi T; Vaeth M; Zernecke A; Frantz S; Hofmann U; Maack C
    Cardiovasc Res; 2022 Jan; 118(1):37-52. PubMed ID: 33537710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities.
    Kashyap D; Sharma A; Tuli HS; Punia S; Sharma AK
    Recent Pat Inflamm Allergy Drug Discov; 2016; 10(1):21-33. PubMed ID: 27531153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review.
    Liao H; Ye J; Gao L; Liu Y
    Biomed Pharmacother; 2021 Jan; 133():110917. PubMed ID: 33217688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
    Buckley LF; Libby P
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientists on the Spot: Esther Lutgens on the immune system and atherosclerosis.
    Patel J; Lutgens E
    Cardiovasc Res; 2018 Dec; 114(14):e113. PubMed ID: 30476016
    [No Abstract]   [Full Text] [Related]  

  • 17. Curcumin targets in inflammation and cancer.
    Deguchi A
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):88-96. PubMed ID: 25772169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells.
    Li M; van Esch BCAM; Wagenaar GTM; Garssen J; Folkerts G; Henricks PAJ
    Eur J Pharmacol; 2018 Jul; 831():52-59. PubMed ID: 29750914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and atherosclerosis--revisited.
    Pant S; Deshmukh A; Gurumurthy GS; Pothineni NV; Watts TE; Romeo F; Mehta JL
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):170-8. PubMed ID: 24177335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and Atherosclerosis: The End of a Controversy.
    Hansson GK
    Circulation; 2017 Nov; 136(20):1875-1877. PubMed ID: 28916641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.